Transcutaneous Acupoint Electrical Stimulation for Cough
Effect of Transcutaneous Acupoint Electrical Stimulation (TAES) on Postoperative Cough in Lung Cancer
Recruiting
N/AInterventional Study
Postoperative CoughLung Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
84 (estimated)
Sponsor
Kong Fanming · Other
Who this trial is looking for
This trial is looking for patients who have a persistent cough after lung cancer surgery. Participants will receive a treatment called Transcutaneous Acupoint Electrical Stimulation to see if it improves their cough symptoms.
Are You a Good Fit for This Trial?
You may be able to join if
I am between 18 and 80 years old.
I have had surgery for lung cancer.
I have a dry cough for at least 2 weeks after my surgery.
I can clearly express my opinions.
I have signed informed consent.
You may not be able to join if
I have been diagnosed with a respiratory disease in the last month.
I have pneumonia based on a chest X-ray.
I have asthma or tuberculosis.
I have uncontrolled hyperthyroidism or severe hypertension.
I have heart disease or a systemic infection.
I have taken steroids in the past 3 months.
I am pregnant or breastfeeding.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Observation and exploration of the improvement in cough symptoms in postoperative lung cancer patients with Transcutaneous Acupoint Electrical Stimulation (TAES), the change in Cough Symptom Score (CSS) compared to baseline, the change in Visual Analog Scale (VAS) score for cough symptoms compared to baseline, the change in total score of Leicester Cough Questionnaire-Mandarin Chinese version (LCQ…
Observation and exploration of the improvement in cough symptoms in postoperative lung cancer patients with Transcutaneous Acupoint Electrical Stimulation (TAES), the change in Cough Symptom Score (CSS) compared to baseline, the change in Visual Analog Scale (VAS) score for cough symptoms compared to baseline, the change in total score of Leicester Cough Questionnaire-Mandarin Chinese version (LCQ-MC) compared to baseline, and overall evaluation of treatment effectiveness by patients. A total of 84 postoperative lung cancer patients with cough were strictly selected according to the inclusion/exclusion criteria and treated and followed up according to the research plan requirements. Clinical observation forms were completed and clinical data were recorded in the database. Statistical analysis was performed on relevant clinical observation indicators to report research results and write related papers.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Age between 18 and 80 years old - Surgery performed under general anesthesia for radical resection of lung cancer or lung cancer resection combined with lymph node dissection.
* Pathological confirmation of primary lung cancer after surgery.
* Duration of persistent dry cough …
Inclusion Criteria:
* Age between 18 and 80 years old - Surgery performed under general anesthesia for radical resection of lung cancer or lung cancer resection combined with lymph node dissection.
* Pathological confirmation of primary lung cancer after surgery.
* Duration of persistent dry cough after lung surgery ≥2 weeks.
* Consciousness, ability to express opinions clearly, and voluntary signing of informed consent.
Exclusion Criteria:
* Patients diagnosed with acute respiratory system diseases within 1 month.
* Patients diagnosed with pneumonia based on chest X-ray.
* Patients with a history of asthma or tuberculosis.
* Patients with uncontrolled hyperthyroidism, severe hypertension, heart disease, systemic infection, coagulation disorders (hypercoagulable state or bleeding tendency), or other severe systemic diseases.
* Patients who have used steroid drugs within the past 3 months.
* Patients who have taken angiotensin-converting enzyme inhibitors (ACEIs) within the past 6 months.
* Patients with surgical incisions, skin allergies, wounds, or infections in the treatment area.
* Patients who cannot tolerate transcutaneous acupoint electrical stimulation or withdraw during the procedure.
* Patients with contraindications to transcutaneous electrical stimulation or implanted electrophysiological devices.
* Patients who are pregnant or breastfeeding.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.